Gradient Investments LLC Teva Pharmaceutical Industries LTD Transaction History

Gradient Investments LLC

14 transactions

Quarter	Operation	Price Per share	shares change	shares Held
Q2 2024 Jul 18, 2024	BUY	$12.78 - $17.4 $3,501 - $4,767	274 Added 137.0%	474 $7,000
Q1 2024 Apr 23, 2024	SELL	$10.67 - $14.43 $10,147 - $13,722	-951 Reduced 82.62%	200 $2,000
Q4 2023 Jan 18, 2024	SELL	$8.12 - $10.63 $6,495 - $8,504	-800 Reduced 41.0%	1,151 $12,000
Q3 2023 Oct 27, 2023	BUY	$7.48 - $10.7 $5,984 - $8,560	800 Added 69.5%	1,951 $19,000
Q1 2023 Apr 17, 2023	BUY	$8.36 - $11.37 $7,950 - $10,812	951 Added 475.5%	1,151 $10,000
Q4 2022 Jan 10, 2023	SELL	$7.95 - $9.48 $6,360 - $7,584	-800 Reduced 80.0%	200 $0
Q1 2022 May 26, 2022	BUY	$7.33 - $9.39 $5,864 - $7,512	800 Added 400.0%	1,000 $9,000
Q1 2021 Apr 21, 2021	SELL	$10.34 - $12.81 $1,364 - $1,690	-132 Reduced 39.76%	200 $2,000
Q3 2020 Oct 06, 2020	BUY	$8.57 - $12.69 $1,131 - $1,675	132 Added 66.0%	332 $3,000
Q4 2019 Jan 15, 2020	SELL	$6.53 - $10.72 $280 - $460	-43 Reduced 17.7%	200 $2,000
Q3 2019 Oct 10, 2019	BUY	$6.16 - $9.6 $264 - $412	43 Added 21.5%	243 $2,000
Q2 2019 Jul 16, 2019	BUY	$8.12 - $15.72 $1,623 - $3,144	200 New	200 $2,000
Q2 2018 Aug 09, 2018	SELL	$16.77 - $24.71 $218 - $321	-13 Closed	0 $0
Q4 2017 Feb 07, 2018	BUY	$11.23 - $19.1 $145 - $248	13	13 $0

625

573M

19.6M

6.77M

Ticker TEVA
Exchange OTC
Sector Healthcare
Industry Drug Manufacturers—Specialty & Generic
Shares Outstandng 1,110,560,000
Market Cap $24.9B
Description
Teva Pharmaceutical Industries Limited, a pharmaceutical company, develops, manufactures, markets, and distributes generic medicines, specialty medicines, and biopharmaceutical products in North America, Europe, and internationally. The company offers sterile products, hormones, high-potency drugs, and cytotoxic substances in various dosage form...

Get notified when there are updates to the investment portfolio of Gradient Investments LLC, based on Form 13F filings with the SEC.

Stay updated on Gradient Investments LLC with notifications on news.